Guobang Pharma Ltd. (605507.SS) SHH
25.45
-0.07(-0.27%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
25.45
-0.07(-0.27%)
Currency In CNY
| Market Cap | 13.76B |
| Enterprise Value | 13.96B |
| P/E Ratio | 17.31 |
| PEG Ratio | -3.02 |
| Price/Sales Ratio | 2.34 |
| Price/Book Ratio | 1.66 |
| Enterprise/Revenue | 2.37 |
| Enterprise/EBITDA | 11.08 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.14 |
| Operating Margin | 0.15 |
| Return On Assets | 0.07 |
| Return On Equity | 0.1 |
| Revenue | 5.99B |
| Revenue/Share | 10.77 |
| Gross Profit | 1.46B |
| EBITDA | 1.39B |
| Net Income | 820.82M |
| Diluted EPS | 1.48 |
| Total Cash | 2.7B |
| Total Cash/Share | 4.84 |
| Total Debt | 1.66B |
| Total Debt/Equity | 0.19 |
| Current Ratio | 3.18 |
| Book Value Per Share | 15.37 |
| 52-Week Change | 32.41 |
| 52-Week High | 29.98 |
| 52-Week Low | 18.53 |
| Moving Average 50 Days | 27.27 |
| Moving Average 200 Days | 24.11 |
| Average Volume | 4.55M |
| Shares Outstanding | 552.99M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.61 |
| Trailing Annual Dividend Yield | 2.38 |
| Payout Ratio | 0.42 |
| Last Split Factor | N/A |
| Last Split Date | N/A |